Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Avalon GloboCare ( (ALBT) ) is now available.
On December 30, 2025, Avalon GloboCare announced that board member and RPM Interactive CEO Michael Mathews participated in an interview with ProactiveInvestors.com, highlighting RPM’s Catch-Up platform, a SaaS solution that automatically generates recap-style videos using generative AI and large language models. Following Avalon’s recent acquisition of RPM Interactive, the company plans to license the Catch-Up platform to content creators, media companies, and brands across news, politics, sports, finance, entertainment and other categories, while also leveraging the technology to boost marketing for its KetoAir™ metabolic health breathalyzer, indicating a strategic effort to integrate AI-driven content tools with its consumer health product portfolio.
More about Avalon GloboCare
Avalon GloboCare Corp. (NASDAQ: ALBT) is a developer of precision diagnostic consumer products with a focus on breathalyzer-based technologies and the advancement of intellectual property in cellular therapy. The company currently markets the FDA-registered KetoAir™ breathalyzer device for wellness and metabolic health monitoring, is pursuing additional diagnostic applications for its breathalyzer platform, maintains an active patent portfolio, and also owns and operates commercial real estate.
Average Trading Volume: 84,267
Technical Sentiment Signal: Sell
Current Market Cap: $6.06M
Learn more about ALBT stock on TipRanks’ Stock Analysis page.